Clinical Trials at University of Colorado
As of August 2026, 74 paid clinical trials are recruiting at University of Colorado, located at 13001 E 17TH PL, AURORA, CO 80045-2570, phone (303) 724-5000 in Aurora, Colorado. Active studies at this site cover conditions such as Breast Cancer, Obesity and Heart Failure. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
74 clinical trials at University of Colorado
·Clear filters·A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Acellular Dermal Matrix Investigation in Breast Reconstruction
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid Tumors
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Human Laboratory Study of Apremilast for Alcohol Use Disorder
Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
Common conditions studied in Aurora
- Breast Cancer (19 active studies)
- Obesity (17 active studies)
- Heart Failure (15 active studies)
- Colorectal Cancer (12 active studies)
- Melanoma (11 active studies)
- Type 1 Diabetes (11 active studies)
Leading research sponsors in Aurora
- University of Colorado, Denver
- VA Office of Research and Development
- National Cancer Institute (NCI)
- Children's Oncology Group
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Aurora?
There are approximately 1,048 recruiting clinical trials in Aurora, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Aurora pay participants?
Most recruiting trials in Aurora compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Aurora?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Aurora?
The most common conditions under active study in Aurora include Breast Cancer (19), Obesity (17), Heart Failure (15), Colorectal Cancer (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Aurora?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Aurora on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Aurora?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Aurora?
Recruiting research sites in Aurora include Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, University of Colorado, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Aurora right now?
The largest active categories in Aurora are Cancer & tumors (285), Diabetes & metabolic (84), Cardiovascular (62). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Colorado?
University of Colorado is located at 13001 E 17TH PL, AURORA, CO 80045-2570. Use the Google Maps link in the intro above to get directions.
How do I contact University of Colorado?
You can reach University of Colorado by phone at (303) 724-5000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.